Regeneron pain study put on hold by the FDA

The US Food and Drug Administration has halted a clinical trial into the efficacy of the potential new painkiller fasinumab. This injectable analgesic is being developed by Teva Pharmaceutical Industries Ltd and Regeneron Pharmaceuticals Inc as a possible alternative to using opiates. Image Credit The study was stopped in the middle stage of a trial […]